Retrospective Evaluation of Ketamine Effectiveness for the Treatment of Acute Battlefield Related Pain
Completed
Conditions studied: Pain, Acute, Analgesia, Amputation, Traumatic, Post Traumatic Stress Disorder, Trauma, Brain
In brief
Using a retrospective review of records, we will conduct a multivariate analysis to examine the relationship between exposure to ketamine, as an analgesic agent in combat related trauma care, the use of additional opioid pain medications, and patient reported pain levels.
Key facts
- Study ID
- NCT04057989
- Run by
- Defense and Veterans Center for Integrative Pain Management
- People needed
- 80
- Starts
- 2014-08-01
- Expected to finish
- 2017-08-30
- Last updated by the study team
- 2019-08-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Battlefield injured from January 2007 to December 2013
- Prescribed a ketamine infusion for acute pain
- Awake, alert (non intubated/sedated), and able to report pain scores 24 hours prior to the start of infusion and up to 48 hours following infusion
You may not qualify if…
- Patients who did not receive an injury in theater and did not receive ketamine while being treated by the APS or WRNMMC/WRAMC hospital staff
- No continuous perineural catheter or epidural placement while on ketamine infusion
- Less than 18 years old
Where it is running
- Walter Reed National Military Medical Center — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.